{"product_id":"ausilium-miao-100g-vet","title":"AUSILIUM MIAO 100G","description":"\u003ch3\u003eAUSILIUM MIAO\u003c\/h3\u003e Mangime complementare in polvere per gatti che contribuisce a proteggere le vie urinarie.\u003cbr\u003e Indicato come rimedio complementare nelle cistiti ed altre infezioni alle vie urinarie, è particolarmente efficace in caso di Escherichia coli, Klebsiella, Enterococcus faecalis, Streptococcus, Staphylococcus, Proteus, Pseudomonas e altri batteri fimbriati. Contrariamente a quanto succede con la terapia antibiotica, i batteri non vengono uccisi, ma eliminati in modo meccanico, trascinati all'esterno con il flusso delle urine. Questo permette di non danneggiare la flora batterica fisiologica, preziosa alleata della salute dell'animale.\u003cbr\u003e AUSILIUM MIAO può essere assunto in caso di cistiti ricorrenti e recidivanti, sia durante le fasi acute, sia come prevenzione.\u003cbr\u003e \u003cbr\u003e \u003cb\u003eIngredienti\u003c\/b\u003e\u003cbr\u003e Maltodestrina, Farina di fegato di maiale, D-Mannosio.\u003cbr\u003e Prodotti naturali botanicamente definiti: Morinda citrifolia L. extract 70.000 mg.\u003cbr\u003e \u003cbr\u003e \u003cb\u003eModalità d'uso\u003c\/b\u003e\u003cbr\u003e Miscelare la polvere alla consueta razione alimentare di cibo umido secondo il seguente dosaggio giornaliero:\u003cbr\u003e - fino a 10 kg di peso: 2 misurini al giorno, in due somministrazioni, per un totale di 3 g;\u003cbr\u003e - oltre i 10 kg di peso: 4 misurini al giorno, in due somministrazioni, per un totale di 6 g.\u003cbr\u003e In fase di prevenzione e mantenimento sarà sufficiente metà dosaggio.\u003cbr\u003e In caso di alimentazione esclusivamente secca inumidire leggermente l'alimento per consentire una buona adesività della polvere e la sua completa assunzione.\u003cbr\u003e È consigliabile effettuare un ciclo di somministrazione di 10-15 giorni, eventualmente ripetibile a giudizio del veterinario.\u003cbr\u003e \u003cbr\u003e \u003cb\u003eAvvertenze\u003c\/b\u003e\u003cbr\u003e Prodotto solo per uso veterinario. Tenere fuori dalla portata dei bambini.\u003cbr\u003e \u003cbr\u003e \u003cb\u003eConservazione\u003c\/b\u003e\u003cbr\u003e Conservare in luogo asciutto ed al riparo dalla luce.\u003cbr\u003e \u003cbr\u003e \u003cb\u003eFormato\u003c\/b\u003e\u003cbr\u003e Confezione da 100 g.\u003cbr\u003e \u003cbr\u003e \u003cb\u003eCod.\u003c\/b\u003e PT267\u003cbr\u003e \u003cbr\u003e \u003cu\u003eBibliografia\u003c\/u\u003e:\u003cbr\u003e 1. Abgottspon D, Rabbani S, Herold J, Jiang X, Ernst B. \u003ci\u003eFimH antagonists for the oral treatment of urinary tract infection: from design and synthesis to in vitro and in vivo evaluation\u003c\/i\u003e. Klein J Med Chem Dec 2010;53:8627-41.\u003cbr\u003e 2. Akihisa T, Matsumoto K, Tokuda H. \u003ci\u003eAnti-inflmmatory and potential cancer chemopreventive constituents of the fruits of Morinda citrifolia (Noni)\u003c\/i\u003e. J Nat Prod 2007;70:754-7.\u003cbr\u003e 3. Alitheen NB, Manaf AA, Yeap SK. \u003ci\u003eImmunomodularory effects of Damnacanthal isolated from roots of Morinda elliptica\u003c\/i\u003e. Pharm Biol 2010;48:446-52.\u003cbr\u003e 4. Altarac S, Papes D. \u003ci\u003eUse of d-mannose in prophylaxis of recurrent urinary tract infections (UTIs) in women\u003c\/i\u003e. BJU Int 2014;113:9-10.\u003cbr\u003e 5. \u003ci\u003eAmerican Chemical Society. Noni plant may yield new drugs to fiht tuberculosis\u003c\/i\u003e. Press Releas at the 2000 International Chemical Congress of Pacifi Basin Societies.\u003cbr\u003e 6. Crepin S, Houle S, Carbanneau ME', Mourez M, Harel J, Dozois CM. \u003ci\u003eDecreased expression of type 1 fibriae by a pst mutant of uropathogenic Escherichia urinary tract infection: contribution to intracellular biofilm development\u003c\/i\u003e. Virulence 2010;1:333-7.\u003cbr\u003e 7. Cusumano CK, Pinkner JS, Han Z, Handerson JP, Croweley JR, Hultgren SJ. \u003ci\u003eTreatment and prevention of urinary tract infection with orally active FimH inhibitors\u003c\/i\u003e. Sci Transl Med Nov 2011;3:109-15.\u003cbr\u003e 8. Gupta RK, Banerjee A, Pathak S. \u003ci\u003eInduction of mitochondrial-mediated apoptosis by Morinda citrifolia (Noni) in human cervical cancer cells\u003c\/i\u003e. Asian Pac J Cancer Prev 2013;14:237-42.\u003cbr\u003e 9. Gupta RK, Patel AK. \u003ci\u003eDo the health claims made for Morinda citrifolia (Noni) harmonize with current scientifi knowledge and evaluation of its biological effects\u003c\/i\u003e. Asian Pac J Canc Prev 2013;14:147-49.\u003cbr\u003e 10. Heinicke R. \u003ci\u003eThe Xeronine system: a new cellular mechanism that explains the health promoting action of NONI and Bromelian\u003c\/i\u003e. Direct Source Pub 2001.\u003cbr\u003e 11. Jiang X, Abgottspon D, Kleeb S, Rabbani S, Scharenberg M, Wittwer M et al. \u003ci\u003eAntiadhesion therapy for urinary tract infections--a balanced PK\/PD profie proved to be key for success\u003c\/i\u003e. J Med Chem 2012;55:4700-13.\u003cbr\u003e 12. Kranjcec B, Papes D, Altarac S. \u003ci\u003eD-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial\u003c\/i\u003e. World J Urol 2013;32:79-84.\u003cbr\u003e 13. Nava CM, Ricciardo G, Valieri M. \u003ci\u003eTrattamento e prevenzione delle recidive delle vaginiti\u003c\/i\u003e. Medicinae Doctor 2013 numero 8.\u003cbr\u003e 14. Pawlus AD, Su BN, Keller WJ. \u003ci\u003eAn anthraquinone with potent quinone reductase-inducing activity and other constituents of the fruits of Morinda citrifolia (Noni)\u003c\/i\u003e. J Nat Prod 2005;68:1720-2.\u003cbr\u003e 15. Porru D, Parmigiani A, Tinelli C, Barletta D, Choussos D, Di Franco C, Bobbi V, Bassi S, Miller O, Gardella B, Nappi RE, Spinillo A and Rovereto B. \u003ci\u003eOral D-mannose in recurrent urinary tract infections in women: A pilot study\u003c\/i\u003e. J Clin Urol 2014; 20 (10) 1–6.\u003cbr\u003e 16. Pratt LA, Kolter R. \u003ci\u003eGenetic analysis of Escherichia coli biofilm formation: roles of flagellar motility, chemotaxis and type 1 pili\u003c\/i\u003e. Mol Microbiol 1998;30:285-93.\u003cbr\u003e 17. Reid G, Sobel JD. \u003ci\u003eBacterial adherence in the pathogenesis of urinary tract infection: a review\u003c\/i\u003e. Clin Infect Dis 1987;9:470-87.\u003cbr\u003e 18. Sharon N. \u003ci\u003eCarbohydrates as future anti-adhesion drugs for infectious diseases\u003c\/i\u003e. Biochim Biophys Acta 2006;1760:527-37.\u003cbr\u003e 19. Umezawa K. \u003ci\u003eIsolation of 1-methoxy-2-foremyl3-hydroxyanthraquinone from M citrifolia and neoplasminhibitors containing the same\u003c\/i\u003e. Japan Kokai Tokyo Koho JP 1992;87:736(94-87, 736).\u003cbr\u003e 20. Wellens A, Garofalo C, Nguyen H, Van Gerven N, Bouckaert J. \u003ci\u003eIntervening with urinary tract infections using anti-adhesives based on crystal structure of the FimH-ologomannose-3 complex\u003c\/i\u003e. PLoS one 2008;3:e2040.\u003cbr\u003e","brand":"DEAKOS","offers":[{"title":"Default Title","offer_id":55382609232197,"sku":"925632729","price":20.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3757\/3189\/files\/925632729_e0249dde-ac4f-4f00-9e35-1ae06d747914.jpg?v=1764590680","url":"https:\/\/farmacievigorito.it\/products\/ausilium-miao-100g-vet","provider":"Farmacie Vigorito","version":"1.0","type":"link"}